Clinical Trials for Non Small Cell Lung Cancer

Find clinical trials for non small cell lung cancer. Discover research opportunities and treatment options in your area.

256 Active Trials Found

Showing 256 trials on this page

Page 13 of 13

A Pilot Study to Understand the Impact of Therapy With Tumour Treating Fields (TTFields) in NSCLC

NCT ID: NCT05698264

This clinical trial is studying a new treatment method called Tumor Treating Fields (TTFields) for patients with non-small cell lung cancer (NSCLC), particularly those with specific genetic mutatio...

Not yet recruiting

Phase: NA Type: interventional Locations: Jerusalem, , Israel

I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy

NCT ID: NCT05537922

The I3LUNG clinical trial is focused on improving treatment for patients with advanced non-small cell lung cancer (NSCLC) by developing a new medical tool that can predict how well immunotherapy wi...

Recruiting

Type: observational Locations: Chicago, Illinois, United States, Athens, , Greece +2 more

First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies

NCT ID: NCT05627960

This clinical trial is investigating a new treatment called AG01, which is an antibody designed to target specific proteins (PGRN/GP88) found on certain cancer cells. It is focused on patients with...

Recruiting

Phase: PHASE1 Type: interventional Locations: Baltimore, Maryland, United States

SBRT Dose Escalation for Reirradiation of Inoperable Lung Lesions

NCT ID: NCT04455438

This clinical trial is studying a type of treatment called Stereotactic Body Radiation Therapy (SBRT) to see how much radiation can be safely given to patients with lung cancer that cannot be surgi...

Recruiting

Phase: NA Type: interventional Locations: Rozzano, Milano, Italy

Trial Exploring Combined Neoadjuvant Therapy With Pembrolizumab/Lenvatinib + Adjuvant Pembrolizumab in Pat. With NSCLC

NCT ID: NCT04875585

This clinical trial is studying a new treatment approach for patients with non-small cell lung cancer (NSCLC), specifically looking at how effective a combination therapy of Pembrolizumab and Lenva...

Recruiting

Phase: PHASE2 Type: interventional Locations: Innsbruck, Tirol, Austria

A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors

NCT ID: NCT05366478

This clinical trial is studying a new treatment called LM103 Injection for patients with advanced solid tumors, specifically melanoma, non-small cell lung cancer, and cervical cancer. The goal of t...

Recruiting

Phase: PHASE1 Type: interventional Locations: Tianjin, , China

Neoadjuvant Lazertinib Therapy in EGFR-Mutation Positive Lung Adenocarcinoma Detected by BALF Liquid Biopsy

NCT ID: NCT05469022

This clinical trial is studying the use of a medication called Lazertinib in patients with early-stage lung cancer that has a specific genetic mutation known as EGFR. The goal is to see if giving L...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seoul, , Korea, Republic Of

An Open-label, Phase 2trial of Sotorasib in KRAS G12C-mutant Non-small-cell Lung Cancer(NSCLC) Patients and a Translational Study to Find Acquired Resistance Mechanism to Sotorasib

NCT ID: NCT05451056

This clinical trial is studying a new treatment called sotorasib for patients with a specific type of lung cancer known as KRAS G12C-mutant non-small cell lung cancer (NSCLC). Lung cancer is a seri...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Seoul, , Korea, Republic Of

Window of Opportunity Trial of Durvalumab (MEDI4736) to Identify Immune Dynamics in Operable Non-small Cell Lung Cancer (NSCLC) (MIRACLE)

NCT ID: NCT05206812

The MIRACLE trial is a research study looking at a treatment called durvalumab for patients with operable non-small cell lung cancer (NSCLC), which is a type of lung cancer that can be removed thro...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Seoul, , Korea, Republic Of

ProSpecTive sAmpling in dRiver muTation Pulmonary Oncology Patients on Tyrosine Kinase Inhibitors (START-TKI)

NCT ID: NCT05221372

The START-TKI clinical trial is studying patients with non-small cell lung cancer (NSCLC) who are being treated with a specific type of treatment called tyrosine kinase inhibitors (TKIs). The main ...

Recruiting

Type: observational Locations: Rotterdam, , Netherlands

The Safety and Efficacy of First-line Lazertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR-mutant Non-small Cell Lung Cancer

NCT ID: NCT05167851

This clinical trial is investigating the combination of a medication called lazertinib and targeted radiation therapy for patients with a specific type of lung cancer known as non-small cell lung c...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Seoul, , Korea, Republic Of

A Window of Opportunity Study for Investigating Drug Tolerant Persister (DTP) to Neoadjuvant Osimertinib in Resectable Non-small Cell Lung Cancer (NSCLC) Harbouring EGFR Mutations

NCT ID: NCT04816838

This clinical trial is investigating the use of a medication called osimertinib in patients with resectable (surgically removable) non-small cell lung cancer (NSCLC) that has specific genetic chang...

Recruiting

Phase: NA Type: interventional Locations: Seoul, , Korea, Republic Of, Seoul, , Korea, Republic Of

Adjuvant Toripalimab Plus Chemotherapy for EGFR/ALK Mutation Negative Stage II-IIIB(N2) NSCLC (LungMate-008)

NCT ID: NCT04772287

The LungMate-008 clinical trial is studying a new treatment for patients with a specific type of lung cancer called non-small cell lung cancer (NSCLC) that has not spread to other parts of the body...

Not yet recruiting

Phase: PHASE3 Type: interventional

Neoadjuvant Durvalumab/Anlotinib /Chemotherapy Plus Curative Resection in Stage III Non-Small-Cell Lung Cancer : A Single-arm Phase II Study

NCT ID: NCT04762030

This clinical trial is investigating a treatment approach for patients with stage III non-small cell lung cancer (NSCLC). The study is testing a combination of three treatments—Durvalumab, Anlotini...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, Shanghai, China

Addition of Radiotherapy to Standard Medical Treatment for Stage IV NSCLC

NCT ID: NCT04530708

This clinical trial is looking at whether adding a moderate dose of radiotherapy to standard medical treatments can help patients with Stage IV non-small cell lung cancer (NSCLC). The goal is to se...

Recruiting

Phase: NA Type: interventional Locations: Umeå, Norrland, Sweden, Stockholm, Stockholm County, Sweden +2 more

Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite Tumors

NCT ID: NCT03392233

This clinical trial is studying a type of treatment called Stereotactic Body Radiation Therapy (SBRT) for patients with spinal tumors caused by breast cancer, prostate cancer, or non-small cell lun...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, Shanghai, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions